Double-blind study of prednicarbate versus fluocortin butyl ester in atopic dermatitis.
Aliaga
A
A
Hospital General de Valencia, Spain.
Rodríguez
M
M
Armijo
M
M
Bravo
J
J
Avila
A L
AL
Mascaro
J M
JM
Ferrando
J
J
Del Rio
R
R
Lozano
R
R
Balaguer
A
A
D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001768:Blister / Q000188:drug therapy; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D004311:Double-Blind Method; D004361:Drug Tolerance; D004890:Erythema / Q000188:drug therapy; D005260:Female; D005448:Fluocortolone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007642:Keratosis / Q000188:drug therapy; D017512:Lichenoid Eruptions / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009824:Ointments; D011239:Prednisolone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011537:Pruritus / Q000188:drug therapy; D012074:Remission Induction
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D009824:Ointments; D005448:Fluocortolone; C011824:fluocortin butyl ester; D011239:Prednisolone; C035287:prednicarbate